10 COPD Clinical Trials in Baltimore, MD (2026)

Q: How do I join a clinical trial in Baltimore?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you.

Recruiting COPD Studies in Baltimore

NCT05033990Recruiting

SPIROMICS Study of Early COPD Progression (SOURCE)

This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals. The study has three main goals:...

Baltimore, MD1,000 participantsUniversity of Massachusetts, Worcester

View Study Details

NCT06177717Recruiting

Deep Functional Phenotyping of the ALA Lung Health Cohort

The goal of this observational study is to learn about lung structure and function in a group of 1000 healthy people aged 25 to 35. The main questions it aims to answer are whether people's bodies, en...

Baltimore, MD1,000 participantsJohns Hopkins University

View Study Details

NCT06376994Recruiting

Multi-Center Clean Air Randomized Controlled Trial in COPD

This is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air quality on reducing COPD exacerbation risk...

Baltimore, MDPHASE3770 participantsJHSPH Center for Clinical Trials

View Study Details

NCT05204888Recruiting

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year a...

Baltimore, MDNA642 participantsTemple University

View Study Details

NCT07059091Recruiting

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

This research is being done to test if a drug called omalizumab can help people with Chronic Obstructive Pulmonary Disease (COPD) and allergies. Each participant will be in the study for about 16 mon...

Baltimore, MDPHASE2334 participantsJohns Hopkins University

View Study Details

NCT07053423Recruiting

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

LPS18583 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 4 study with 2 treatment groups. The purpose of this study is to assess the effect of dupilumab compare...

Baltimore, MDPHASE4218 participantsSanofi

View Study Details

NCT05297279Recruiting

OMEGA - Dietary Intervention - COPD Trial

A randomized controlled trial of a food delivery dietary intervention targeting increased omega-3 intake to determine whether dietary modifications can improve Chronic Obstructive Pulmonary Disease (C...

Baltimore, MDNA200 participantsJohns Hopkins University

View Study Details

NCT04302272Recruiting

STRIVE Post-Market Registry Study

This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-m...

Baltimore, MD150 participantsOlympus Corporation of the Americas

View Study Details

NCT06751537Recruiting

Effectiveness of the WearME System for COPD Severity and Respiratory Function

This observational study evaluates the effectiveness of the WearME system in monitoring COPD severity and respiratory function by comparing its measurements to standard spirometry, capnography, and ot...

Baltimore, MD128 participantsLASARRUS Clinic and Research Center

View Study Details

NCT07366034Recruiting

A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)

This study is open to children and adolescents aged 2 to 17 years with interstitial lung disease (ILD). Nerandomilast has just been approved in some countries to help adults with a lung condition call...

Baltimore, MDPHASE335 participantsBoehringer Ingelheim

View Study Details

About COPD Clinical Trials in Baltimore

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that makes breathing difficult, primarily caused by smoking. It includes emphysema and chronic bronchitis. Treatment involves bronchodilators, inhaled steroids, pulmonary rehabilitation, and oxygen therapy.

There are currently 10 copd clinical trials recruiting participants in Baltimore, MD. These studies are seeking a combined 4,477 participants. Research is being sponsored by University of Massachusetts, Worcester, Johns Hopkins University, JHSPH Center for Clinical Trials and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

COPD Clinical Trials in Baltimore — FAQ

Are there copd clinical trials in Baltimore?

Yes, there are 10 copd clinical trials currently recruiting in Baltimore, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Baltimore?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.

Are clinical trials in Baltimore free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.

What copd treatments are being tested?

The 10 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for copd.

Data updated October 12, 2026 from ClinicalTrials.gov